Clarius Group, LLC Laboratory Corp Of America Holdings Transaction History

Clarius Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$209.01 - $232.56 $3,135 - $3,488	-15 Reduced 1.52%	975 $212,000
Q4 2023 Jan 29, 2024	SELL	$197.69 - $227.29 $13,838 - $15,910	-70 Reduced 6.6%	990 $225,000
Q3 2023 Oct 19, 2023	SELL	$201.05 - $221.7 $8,645 - $9,533	-43 Reduced 3.9%	1,060 $213,000
Q2 2023 Aug 09, 2023	SELL	$211.93 - $241.33 $7,841 - $8,929	-37 Reduced 3.25%	1,103 $266,000
Q1 2023 Apr 17, 2023	BUY	$213.32 - $257.83 $8,532 - $10,313	40 Added 3.64%	1,140 $261,000
Q4 2022 Jan 25, 2023	BUY	$203.72 - $248.97 $12,630 - $15,436	62 Added 5.97%	1,100 $259,000
Q3 2022 Oct 24, 2022	BUY	$204.81 - $262.19 $14,541 - $18,615	71 Added 7.34%	1,038 $213,000
Q2 2022 Aug 10, 2022	BUY	$213.86 - $277.87 $23,952 - $31,121	112 Added 13.1%	967 $227,000
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $16,024 - $18,538	59 Added 7.41%	855 $269,000
Q3 2021 Oct 18, 2021	BUY	$274.82 - $308.34 $4,122 - $4,625	15 Added 1.92%	796 $224,000
Q2 2021 Aug 06, 2021	BUY	$251.87 - $278.14 $196,710 - $217,227	781 New	781 $215,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarius Group, LLC with notifications on news.